Volume 64, Issue 5 pp. 819-821
Research Article

Effect of aspirin on fate of 14C-acetaminophen in guinea pigs

L. W. Whitehouse

Corresponding Author

L. W. Whitehouse

Drug Research Laboratories, Health Protection Branch, Tunney's Pasture, Ottawa, Canada K1A OL2

Drug Research Laboratories, Health Protection Branch, Tunney's Pasture, Ottawa, Canada K1A OL2Search for more papers by this author
C. J. Paul

C. J. Paul

Drug Research Laboratories, Health Protection Branch, Tunney's Pasture, Ottawa, Canada K1A OL2

Search for more papers by this author
B. H. Thomas

B. H. Thomas

Drug Research Laboratories, Health Protection Branch, Tunney's Pasture, Ottawa, Canada K1A OL2

Search for more papers by this author
First published: May 1975
Citations: 2

Abstract

The interaction of 14C-acetaminophen, 150 mg/kg (20 μCi/kg), and orally administered aspirin, 200 mg/kg, was studied in male guinea pigs. Aspirin-pretreated animals possessed higher 14C blood levels than controls. Paper chromatography of 0–6-hr urines demonstrated that pretreated animals excreted significantly greater amounts of mercapturate than controls; however, it was only a minor metabolite, accounting for 1–3% of the counts in the urine. The major metabolite, the glucuronide, accounted for 90% of the counts, with free acetaminophen and its sulfate responsible for the remaining counts. Tissue distribution studies indicated that blood plasma and kidneys from aspirin-pretreated animals possessed statistically higher 14C levels than did control tissues. Bile duct and ureter cannulation experiments indicated that aspirin inhibited the concentrating processes into the urine and bile.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.